ABSTRACT
Although vitamin D supplementation appears to be a promising intervention for reducing risks of cancer, cardiovascular disease, and other chronic diseases, existing evidence on its benefits and risks is limited and inconclusive. Recruitment is now under way for the Vitamin D and Omega-3 Trial (VITAL), the first large-scale randomized clinical trial of these nutritional agents for the primary prevention of cancer and cardiovascular disease.
Footnotes
↵* Dr. Manson has received funding from the National Institutes of Health to conduct a large-scale randomized trial of vitamin D and omega-3 fatty acids for the prevention of cardiovascular disease and cancer.
- Copyright © 2010 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- Vitamin Supplementation and Stroke Prevention
- The Short-Term Effects of Vitamin D Repletion on Cholesterol: A Randomized, Placebo-Controlled Trial
- Low Dietary Vitamin D Predicts 34-Year Incident Stroke: The Honolulu Heart Program
- Vitamin D May Not Improve Lipid Levels: A Serial Clinical Laboratory Data Study
- Sex/Gender Differences in Cardiovascular Disease Prevention: What a Difference a Decade Makes